menu
    • menu

    Company profile for IO Biotech

    NEW Drugs in Dev: 5
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies. We are focused on the development of immunological treatment of cancer with a research profile based on successful R&D discoveries, translated into numerous clinical trials. IO Biotech has achieved a proven track record of progressing pre-clinical and clinical compounds: Two lead anti-cancer therapies targeting I...
    IO Biotech is a clinical stage biotech company developing disruptive immune modulating anti-cancer therapies. We are focused on the development of immunological treatment of cancer with a research profile based on successful R&D discoveries, translated into numerous clinical trials. IO Biotech has achieved a proven track record of progressing pre-clinical and clinical compounds: Two lead anti-cancer therapies targeting IDO and PD-L1 are in clinical development Several compounds finalizing the preclinical phase

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    IO BiotechDenmark Flag
    Country
    Country
    Denmark
    Address
    Address
    IO Biotech ApS Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://iobiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/io-biotech/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IO Biotech Provides Corporate Update
    IO Biotech Provides Corporate Update

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229500/0/en/IO-Biotech-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    IO Biotech Announces Exploration Of Strategic Alternatives
    IO Biotech Announces Exploration Of Strategic Alternatives

    21 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/21/3222527/0/en/IO-Biotech-Announces-Exploration-of-Strategic-Alternatives.html

    GLOBENEWSWIRE
    21 Jan 2026
    Share Share
    IO Biotech Publishes 5-Year Phase 1/2 Trial Outcomes in Nature
    IO Biotech Publishes 5-Year Phase 1/2 Trial Outcomes in Nature

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205841/0/en/IO-Biotech-Announces-Publication-of-Five-year-Clinical-Outcomes-of-Phase-1-2-Trial-in-Nature-Communications.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    IO Biotech To Participate In December Investor Conferences
    IO Biotech To Participate In December Investor Conferences

    26 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/26/3195234/0/en/IO-Biotech-Announces-Participation-in-Upcoming-December-Investor-Conferences.html

    GLOBENEWSWIRE
    26 Nov 2025
    Share Share
    IO Biotech Reports Q3 2025 Financial Results & Business Result
    IO Biotech Reports Q3 2025 Financial Results & Business Result

    14 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/14/3188282/0/en/IO-Biotech-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Business-Highlights.html

    GLOBENEWSWIRE
    14 Nov 2025
    Share Share
    IO Biotech To Participate In Investor Conferences
    IO Biotech To Participate In Investor Conferences

    12 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/12/3186252/0/en/IO-Biotech-Announces-Participation-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    12 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search